Sorry you missed the 2016 event

Market Access & Real World Evidence EU returned to Amsterdam on May 10 and 11 2016 for its 2nd annual edition. Featuring 150+ attendees and 40 expert speakers, this event brought together Europe's most senior market access, pricing, reimbursement, HTA, real world data and HEOR professionals for 2 days of unmissable learning and networking opportunities.

Every year at Europe's no.1 meeting place for market access, pricing, reimbursement & data professionals, delegates learn how to:

  • Accelerate access to the market with an in-depth understanding of innovative pricing and HTA collaborations across Europe
  • Achieve excellence in evidence: engage your key stakeholders with real world data for a long-term patient-centric strategy
  • Partner with patients to maintain and expand market access for the win-win outcomes payers and providers are looking for
  • Reorganise your internal approach break down your functional silos to provide payers with the robust evidence they want and need

2016 Speakers

View The Full Speaker Line-Up

Supporters and Attendees in 2016

  • AstraZeneca
    Catalan Health Service
  • celgene
    daiichi sankyo
  • novartis
  • teva
  • JAnssen

Our Track-Record of Proven Success

Conferences promise a lot - we know. Below are a few takeaways from the last year's Summit highlighting the valuable insights the attendees took away …


call our sessions essential


said they will likely return again next year


rated the program very well run

What our Delegates are saying

  • Bayer

    "This was one of the most relevant and comprehensive conferences, which I have attended in recent years. The speakers and meeting chairs were well selected."

    - Karel Mechelse, Market Access Strategy Leader, Bayer
  • Novartis

    "Well worth investing in... a place to exchange views and perspectives"

    - Frederic de Reydet, Global Market Access Director, Novartis
  • Eli-Lilly

    "An excellent representation of key European decision makers"

    - Myriam Zylberman, Senior Director - EU Payer Strategy, Eli Lilly
  • Janssen

    "A fascinating meeting of diverse speakers who outlined numerous themes around the need to prove the validity and trustworthiness of RWE, versus RCTs, with an emphasis on “real time” versus “real world”. Thank you eyeforpharma!"

    - Nigel Hughes, Global Director Marketing/ Health Information Technology Strategy Leader, Janssen

Got a question? Get in touch below!

Aidan Brain

Aidan Brain

VP Market Access
+1800 814 3459 x7513 (US)
+44 (0) 207 375 7513 (Global)

Global Sponsor

  • IMS Health

Gold Sponsors

  • CharlesRiver
  • Covance
  • Exec Insight
  • idis
  • IGES
  • Kinapse
  • Laser
  • Saama
  • Pope Woodhead
  • svmpharm

Supporting Sponsor

  • Health Advances


  • CK-Aspire
Don't Miss Out...
Reserve Your Pass Now!